Gsk (GLAXF) FCF Margin (2009 - 2026)

Gsk (GLAXF) recorded quarterly FCF Margin of 20.59% in Q1 2026, down 13.85% quarter-over-quarter from 23.9% in Q4 2025, and up 52.0% on a YoY basis from 13.55% in Q1 2025.

Gsk (GLAXF) FCF Margin (2009 - 2026) Analysis & Trends

Gsk's FCF Margin history runs 18 years deep, the most recent figure standing at 20.59% for Q1 2026.

  • In Q1 2026, FCF Margin rose 52.0% year-over-year to 20.59%; the TTM figure through Mar 2026 stood at 12.79% (down 126.0% YoY), while the FY2025 annual figure was 19.57%, up 314.0% from the prior year.
  • FCF Margin was 20.59% for Q1 2026 at Gsk, down from 23.9% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 38.04% in Q1 2022 to a low of 2.18% in Q4 2022.
  • Historically, FCF Margin has averaged 12.31% across 5 years, with a median of 5.8% in 2023.
  • Biggest YoY gain for FCF Margin was 2772 bps in 2022; the steepest drop was 3936 bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 2.18% in 2022, then surged by 1145 bps to 22.8% in 2023, then retreated by 4 bps to 21.77% in 2024, then advanced by 10 bps to 23.9% in 2025, then dropped by 14 bps to 20.59% in 2026.
  • The last three FCF Margin figures came in at 20.59% (Q1 2026), 23.9% (Q4 2025), and 3.64% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 20.59%
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 15.19%
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 6.09%
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 23.76%
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 17.97%
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 17.14%
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 34.87%
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 93.16%
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 6.59%
10 Gsk - - 7.76 Bn 20.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 20.59%
Dec 31, 2025 23.90%
Sep 30, 2025 3.64%
Jun 30, 2025 3.21%
Mar 31, 2025 20.08%
Dec 31, 2024 21.77%
Sep 30, 2024 3.81%
Jun 30, 2024 3.83%
Mar 31, 2024 18.66%
Dec 31, 2023 22.80%
Sep 30, 2023 3.67%
Jun 30, 2023 4.12%
Mar 31, 2023 7.48%
Dec 31, 2022 -2.18%
Sep 30, 2022 3.51%
Mar 31, 2022 38.04%
Dec 31, 2021 36.36%
Sep 30, 2021 42.87%
Jun 30, 2021 26.22%
Mar 31, 2021 10.32%